Paths Toward the Re-Biologization of Race in Modern Biomedical Research, Practice, and Product Development
This chapter considers how and where race enters modern biomedicine, with an emphasis on the role of federal regulatory frameworks and mandates in incentivizing the introduction of racial categories in research and practice. Foremost among these are initiatives such as the National Institutes of Health Revitalization Act of 1993 and the Food and Drug Modernization Act (FDMA) of 1997. This chapter also considers the implications of how federally sponsored biobanks, which compile genetic data from around the world, frequently organize their vast data sets using population groupings that often become collapsed into racial categories reflecting the U.S. Office of Management and Budget (OMB) mandate. This sets the stage for exploring what happens to race after it enters biomedical research and practice by looking for where it travels, how and by whom it is taken up, and what diverse purposes it serves—both intentional and unintentional.
Columbia Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us .